Recommended

Subscribers

Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +

New

Aesica introduces serialisation services at packaging site in Italy

Packaging lines actively monitor the integrity and authenticity of products

Packaging | Europe

Mitochondria lead to new targets for drug discovery

Mitochondrial dysfunction is seen as an important factor in many diseases, making mitochondria prime targets for therapeutics. Dr Sarah Houlton reports on the latest research and its implications for drug discovery

R and D

Venezuela pharma sector starved of foreign currency

Slow issue of health permits is further complicating matters

Latin America

UHPLC the technology and packing

The science of separation is key to many aspects of drug discovery and development, and frequently involves ultra high-performance liquid chromatography. Richard Henry, Consultant, and Wayne Way, Supelco, look at its development and give advice on which packing to choose

Measurement and Analysis | Manufacturing

RAPS establishes new chapter in Taiwan

First in Asia for the regulatory society

Regulatory | Asia

The future of vaccine R&D

Vaccine development has produced some of the greatest human health benefits since the start of medicinal science, but can future developments match those of the past?

R and D | Vaccines

Multisorb launch new product for nutraceutical applications

Active packaging specialist Multisorb Technologies has launched its new range of sorbents for nutraceutical applications.

Packaging

Make more of moisture-activated dry granulation

Moisture-activated dry granulation (MADG) is a simple, cost-effective way to create granules that can offer specific solutions to formulation issues. In the face of an industry resistant to change, Aesica argues that MADG deserves greater consideration

Manufacturing

Smart timing for solid form screens

Understanding the solid state nature of an API is key, but where should this be integrated into the development pipeline? Julian Northen and Adam Moorhouse, Onyx Scientific, discuss how best to deploy screening to mitigate the risk of late stage attrition

R and D | Measurement and Analysis